路透9月2日 - STAAR Surgical STAA.O的最大股东Broadwood Partners周二表示，它打算投票反对爱尔康ALCC.S收购该公司的提议，称这家瑞士眼科护理集团的报价没有反映出STAAR最近的财务改善。
这家投资公司持有STAAR公司27.5%的股份，它对STAAR公司董事会在没有经过全面的出售程序的情况下选择出售公司感到失望，并敦促董事会重新考虑对收购提议的建议。
该组织还对拟议交易的时机与即将公布的临床试验结果之间的关系表示担忧。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.